Enfusion Stock Forward View - Price Action Indicator

ENFNDelisted Stock  USD 10.76  0.00  0.00%   
As of now, RSI for Enfusion stands at 43, indicating moderately negative momentum. This range suggests moderated price movement without extreme directional pressure.
Momentum
Sell Extended
 
Oversold
 
Overbought
Price forecasting for Enfusion requires integrating several analytical layers. This module contributes the sentiment layer - assessing whether investor enthusiasm around Enfusion is driving its price away from fundamental value.
Hype-based context for Enfusion connects recent headlines with price response and peer activity.
Enfusion after-hype prediction price
    
  $ 10.76  
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
  
Enfusion has market cap of 1.02 B, P/E of 0.11, operating margin of 2.99%. Use Investing Opportunities to explore allocation context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Enfusion Additional Predictive Modules

Most predictive techniques to examine Enfusion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enfusion using various technical indicators. When you analyze Enfusion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Enfusion has current Price Action Indicator of -0.04. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Enfusion VolatilityBacktest EnfusionInformation Ratio  

Enfusion Trading Date Momentum

On March 11 2026 Enfusion was traded for 10.76 at the closing time. The top price for the day was 10.87 and the lowest listed price was 10.74 . There was no trading activity during the period 0.0. Lack of trading volume on March 11, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Enfusion to competition

Enfusion Related Equities

The following equities are related to Enfusion within the Information Technology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Enfusion against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
 Risk & Return  Correlation

Enfusion Market Strength Events

Market strength indicators applied to Enfusion stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Enfusion.

Enfusion Risk Indicators

Risk indicator analysis for Enfusion is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Enfusion's investment, investors can make informed decisions about position sizing and risk mitigation.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Enfusion

Coverage intensity for Enfusion matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Enfusion Short Properties

Short sentiment tied to Enfusion matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding129.6 M
Cash And Short Term Investments54.5 M
Enfusion has market cap of 1.02 B, P/E of 0.11, operating margin of 2.99%. Use Investing Opportunities to explore allocation context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Analysis related to Enfusion should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Enfusion Stock

Delisted instruments like Enfusion often face wider spreads and reduced transparency.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.